April 23, 2012
Health Awareness Topics - April 2012
- Alcohol Awareness Month (see related guidelines)
- National Autism Awareness Month (see related guidelines)
New clinician and consumer guides added! Visit the AHRQ Evidence Reports page for a listing of reports produced under AHRQ's Evidence-based Practice Program and Effective Health Care Program.
The Guidelines International Network (G-I-N) Conference 2012, will be held August 22-25, 2012 in Berlin, Germany. Registration is now open.
U.S. Food and Drug Administration (FDA) Advisory
- April 20, 2012: Aliskiren-containing Medications : FDA notified healthcare professionals of possible risks when using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with diabetes or kidney (renal) impairment. These drug combinations should not be used (are contraindicated) in patients with diabetes. In addition, avoid use of aliskiren with ARBs or ACEIs in patients with moderate to severe renal impairment. The labels for the aliskiren drugs are being updated based on preliminary data from a clinical trial